Biomaterial Database

Clinical pharmacokinetics of oral cephalosporins. 1995

K Stoeckel, and W L Hayton, and D J Edwards

CLINPHARM SUPPORT, Basel, Switzerland.

UI	MeSH Term	Description	Entries
D007408	Intestinal Absorption	Uptake of substances through the lining of the INTESTINES.	Absorption, Intestinal
D007674	Kidney Diseases	Pathological processes of the KIDNEY or its component tissues.	Disease, Kidney,Diseases, Kidney,Kidney Disease
D008657	Metabolic Clearance Rate	Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site.	Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D011485	Protein Binding	The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments.	Plasma Protein Binding Capacity,Binding, Protein
D001826	Body Fluids	Liquid components of living organisms.	Body Fluid,Fluid, Body,Fluids, Body
D002511	Cephalosporins	A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid.	Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D002627	Chemistry, Physical	The study of CHEMICAL PHENOMENA and processes in terms of the underlying PHYSICAL PHENOMENA and processes.	Physical Chemistry,Chemistries, Physical,Physical Chemistries
D002648	Child	A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL.	Children
D004347	Drug Interactions	The action of a drug that may affect the activity, metabolism, or toxicity of another drug.	Drug Interaction,Interaction, Drug,Interactions, Drug
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K Stoeckel, and W L Hayton, and D J Edwards

Pharmacokinetics of oral cephalosporins.

November 1978, The Journal of pediatrics,

K Stoeckel, and W L Hayton, and D J Edwards

Clinical pharmacokinetics of five oral cephalosporins in calves.

September 1987, Research in veterinary science,

K Stoeckel, and W L Hayton, and D J Edwards

The pharmacokinetics of oral cephalosporins.

January 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,

K Stoeckel, and W L Hayton, and D J Edwards

Pharmacokinetics of oral cephalosporins: cephradine cephalexin.

October 1978, Journal of pharmaceutical sciences,

K Stoeckel, and W L Hayton, and D J Edwards

Pharmacokinetics of high-dose oral cephalosporins.

April 1979, Journal of clinical pharmacology,

K Stoeckel, and W L Hayton, and D J Edwards

Clinical pharmacokinetics of newer cephalosporins.

May 1995, Clinical pharmacokinetics,

K Stoeckel, and W L Hayton, and D J Edwards

Comparative pharmacokinetics of the new oral cephalosporins.

January 1994, Drugs,